Name | 8-[[5-chloro-2-(4-methylpiperazin-1-yl)pyridine-4-carbonyl]amino]-1-(4-fluorophenyl)-4,5-dihydrobenzo[g]indazole-3-carboxamide |
---|---|
Synonyms | pha-408 |
Description | PHA 408 (PHA-408) is a potent, selective and orally active IκB kinase-2 (IKK-2) inhibitor. PHA 408 is a powerful anti-inflammatory agent against lipopolysaccharide (LPS)- and cigarette smoke (CS)-mediated lung inflammation[1]. |
---|---|
Related Catalog | |
Target |
IKK-2 |
References |
Molecular Formula | C29H27ClFN7O2 |
---|---|
Molecular Weight | 560.02 |
Exact Mass | 559.19000 |
PSA | 113.86000 |
LogP | 5.19950 |
Precursor 1 | |
---|---|
DownStream 0 |